Kolexia
Bonnet Benjamin
Cardiologie
Clinique Saint Vincent Besançon
Besançon, France
57 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Embolie Embolie pulmonaire Syndrome coronarien aigu Thrombose Prolapsus Atteinte rénale aigüe Hémorragie Défaillance cardiaque Infarctus du myocarde avec sus-décalage du segment ST

Industries

Novartis
5 collaboration(s)
Dernière en 2023
Boston Scientific
3 collaboration(s)
Dernière en 2023
Bayer
2 collaboration(s)
Dernière en 2022
Novo Nordisk
2 collaboration(s)
Dernière en 2020

Dernières activités

Renal dysfunction improves risk stratification and may call for a change in the management of intermediate- and high-risk acute pulmonary embolism: results from a multicenter cohort study with external validation.
Critical care (London, England)   09 février 2021
Renal function improves mortality prediction in acute pulmonary embolism: results of a multicentre cohort study with external validation in the RIETE registry
ESC Congress 2020 - The Digital Experience 29 August - 1 September 2020 Abstract Supplement   01 novembre 2020
Outcomes and incremental prognostic value of renal dysfunction after acute pulmonary embolism
Les 30èmes Journées Européennes de la Société Française de Cardiologie   01 janvier 2020
Clinical patterns and significance of non-compliance with guideline-recommended treatment of acute pulmonary embolism.
Archives of cardiovascular diseases   02 novembre 2019
P2767Outcomes and incremental prognostic value of renal function impairment after acute pulmonary embolism
ESC Congress 2019 together with World Congress of Cardiology 31 August – 4 September 2019, Paris - France   01 octobre 2019
Efficacy and safety of direct oral anticoagulants in intermediate-high risk pulmonary embolism: Results from a multidisciplinary multicenter prospective registry
Les 29èmes Journées Européennes de la Société Française de Cardiologie, deuxième partie   01 avril 2019
EARLY PRESCRIPTION OF DIRECT ORAL ANTICOAGULANTS FOR ACUTE INTERMEDIATE-HIGH RISK PULMONARY EMBOLISM
ACC.19: The American College of Cardiology 68th Annual Scientific Sessions   12 mars 2019
NON-RECOMMENDED DOSING OF DIRECT ORAL ANTICOAGULANTS IN THE TREATMENT OF ACUTE PULMONARY EMBOLISM IS RELATED TO AN INCREASED RATE OF ADVERSE EVENTS
ACC.19: The American College of Cardiology 68th Annual Scientific Sessions   12 mars 2019
CLINICAL IMPACT OF MILD TO MODERATE RENAL FUNCTION IMPAIRMENT AFTER ACUTE PULMONARY EMBOLISM
ACC.19: The American College of Cardiology 68th Annual Scientific Sessions   12 mars 2019
Prognostic impact of non-compliance with guidelines-recommended treatment of acute pulmonary embolism: Results of a prospective multicenter registry
Les 29èmes Journées Européennes de la Société Française de Cardiologie   01 janvier 2019